BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
210 results:

  • 1. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
    Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The mechanisms behind the dual role of long non-coding RNA (lncRNA) metastasis suppressor-1 in human tumors: Shedding light on the molecular mechanisms.
    Abdullaev B; Alsaab HO; Hjazi A; Alkhafaji AT; Alawadi AH; Hamzah HF
    Pathol Res Pract; 2024 Apr; 256():155189. PubMed ID: 38452581
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 4. The Prognostic and Therapeutic Roles of ARL-6 Gene in Hepatocellular Carcinoma.
    Wang J; Che F; Zhao Y; Wei L; Chen D; Dai C; Zhang B; Zhou X; Yang B; Chen Z
    Int J Med Sci; 2024; 21(2):207-218. PubMed ID: 38169538
    [No Abstract]    [Full Text] [Related]  

  • 5. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
    Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
    BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased Incidence of liver Metastases in Colorectal
    Garrett C; Cristaudo A; Barat S; Morris DL
    Anticancer Res; 2023 Oct; 43(10):4657-4662. PubMed ID: 37772565
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients.
    Peng H; Zou Z; Xiang Z; Lu X; Zhang Y; Peng X
    Medicine (Baltimore); 2023 Aug; 102(34):e34741. PubMed ID: 37653738
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.
    Chavda V; Zajac KK; Gunn JL; Balar P; Khadela A; Vaghela D; Soni S; Ashby CR; Tiwari AK
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1821. PubMed ID: 37344125
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.
    Zhao K; Erinjeri JP; Sotirchos VS; Alexander ES; Moussa AM; Marinelli B; Ziv E; Sofocleous CT; Abou-Alfa GK; Jarnagin WR; Karimi A; Yarmohammadi H
    Abdom Radiol (NY); 2023 Jul; 48(7):2434-2442. PubMed ID: 37145313
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
    Liao X; Lai J; Lin J; Zhang D
    Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Secretory Factors from Calcium-Sensing Receptor-Activated SW872 Pre-Adipocytes Induce Cellular Senescence and A Mitochondrial Fragmentation-Mediated Inflammatory Response in HepG2 Cells.
    Briones-Suarez L; Cifuentes M; Bravo-Sagua R
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982291
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
    Hong L; Aminu M; Li S; Lu X; Petranovic M; Saad MB; Chen P; Qin K; Varghese S; Rinsurongkawong W; Rinsurongkawong V; Spelman A; Elamin YY; Negrao MV; Skoulidis F; Gay CM; Cascone T; Gandhi SJ; Lin SH; Lee PP; Carter BW; Wu CC; Antonoff MB; Sepesi B; Lewis J; Gibbons DL; Vaporciyan AA; Le X; Jack Lee J; Roy-Chowdhuri S; Routbort MJ; Gainor JF; Heymach JV; Lou Y; Wu J; Zhang J; Vokes NI
    Nat Commun; 2023 Feb; 14(1):695. PubMed ID: 36755027
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma.
    Ke C; Dai S; Xu F; Yuan J; Fan S; Chen Y; Yang L; Li Y
    BMC Cancer; 2023 Jan; 23(1):25. PubMed ID: 36611155
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1.
    Chen M; Pan Y; Liu H; Ning F; Lu Q; Duan Y; Gan X; Lu S; Hou H; Zhang M; Tian Y; Lash GE
    Cell Oncol (Dordr); 2023 Jun; 46(3):571-587. PubMed ID: 36580262
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Radiomics based on preoperative rectal cancer MRI to predict the metachronous liver metastasis.
    Li ZF; Kang LQ; Liu FH; Zhao M; Guo SY; Lu S; Quan S
    Abdom Radiol (NY); 2023 Mar; 48(3):833-843. PubMed ID: 36529807
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exploring the mechanisms underlying the therapeutic effect of the
    Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
    Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets.
    Fujita M; Chen MM; Siwak DR; Sasagawa S; Oosawa-Tatsuguchi A; Arihiro K; Ono A; Miura R; Maejima K; Aikata H; Ueno M; Hayami S; Yamaue H; Chayama K; Lee JS; Lu Y; Mills GB; Liang H; Nishizuka SS; Nakagawa H
    Nat Commun; 2022 Oct; 13(1):6481. PubMed ID: 36309506
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
    Yan C; Niu Y; Ma L; Tian L; Ma J
    J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters.
    Rimini M; Loi E; Fabregat-Franco C; Burgio V; Lonardi S; Niger M; Scartozzi M; Raposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Rizzato M; Nichetti F; Lai E; Cappetta A; Macarulla T; Fassan M; De Braud F; Pretta A; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Zavattari P; Casadei-Gardini A
    Eur J Cancer; 2022 Nov; 175():299-310. PubMed ID: 36182816
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.